Update shared on 27 Nov 2025
Fair value Decreased 1.52%Analysts have modestly reduced their price targets for Silgan Holdings, with the consensus fair value estimate decreasing by $0.76 to $49.64. This change is attributed to revised earnings guidance and persistent growth headwinds.
Analyst Commentary
Recent street research has revealed a mix of optimism and caution among analysts regarding the outlook for Silgan Holdings. Despite some positive shifts in company strategy, there are notable concerns influencing their adjusted price targets and ratings.
Bullish Takeaways- Analysts highlight the company's increased emphasis on its high-margin dispensing segment, viewing this transformation as a driver for potential margin expansion over time.
- Strategic acquisitions aimed at strengthening higher-value business lines are seen as a positive step in supporting long-term growth and improving profitability.
- Some analysts maintain Buy ratings, expecting that ongoing cost-cutting and product mix improvements will help offset near-term headwinds and provide operational resilience.
- There is a consensus that Silgan's ongoing portfolio transformation remains underappreciated by the market. This suggests room for future valuation upside if execution continues to improve.
- Bearish analysts express concern over the company's reduced guidance for next year and lingering destocking issues. These suggest persistent slowdowns in top-line growth.
- Recent quarters have been marked by inconsistent execution, with unexpected discrete items and cautious management commentary contributing to further downside risk in estimates.
- Lowered price targets reflect worries about signs of weakening U.S. consumer discretionary spending, implying uncertainty around end-market demand recovery.
- Growth headwinds and valuation adjustments have prompted a cautious stance, with the sector's overall risk/reward balance seen as less compelling at current share levels.
What's in the News
- Shawn C. Fabry has been elected as Chief Financial Officer, effective November 6, 2025. He will succeed Ms. Ulmer following an extensive leadership tenure (Key Developments).
- The Board of Directors has authorized a new share buyback plan as of November 5, 2025 (Key Developments).
- Silgan Holdings has announced a share repurchase program to buy back up to $500 million of its shares, with an expiration date of December 31, 2029 (Key Developments).
- Between July and November 2025, the company repurchased a total of 1,538,123 shares for over $68 million. This brings cumulative buybacks to more than 6.2 million shares, or 5.69% of outstanding shares (Key Developments).
Valuation Changes
- Consensus Analyst Price Target: The consensus fair value estimate has declined modestly from $50.40 to $49.64.
- Discount Rate: The discount rate has decreased slightly from 8.52% to 8.50%.
- Revenue Growth: Projected revenue growth has edged down from 3.21% to 3.18%.
- Net Profit Margin: The estimated net profit margin has fallen from 5.99% to 5.78%.
- Future P/E: The future price-to-earnings ratio has risen slightly from 15.53x to 15.85x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.